Andreia M. Leopoldino

Bandeirantes Avenue
Ribeirao Preto, SP 14040903, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

High level of KMT5C is associated to better prognosis and its knockdown increases proliferation in head and neck cancer.

High level of KMT5C is associated to better prognosis and its knockdown increases proliferation in head and neck cancer.

Journal: Epigenomics
Published: December 24, 2025

Design, Synthesis, and Evaluation of Naphthyl Pyrazino-Pyrido-Pyrimidinones Targeting the Phosphoinositide 3-Kinase/Alpha-Serine/Protein Kinase B/Mammalian Target of Rapamycin Pathway.

Design, Synthesis, and Evaluation of Naphthyl Pyrazino-Pyrido-Pyrimidinones Targeting the Phosphoinositide 3-Kinase/Alpha-Serine/Protein Kinase B/Mammalian Target of Rapamycin Pathway.

Journal: ChemistryOpen
Published: December 16, 2025

Novel patient-derived tongue squamous cell carcinoma cell lines from non-smokers: 3D and in vivo models for drug response studies.

Novel patient-derived tongue squamous cell carcinoma cell lines from non-smokers: 3D and in vivo models for drug response studies.

Journal: Medical oncology (Northwood, London, England)
Published: September 22, 2025

Design, Synthesis, and Selective Antiproliferative Activity of Indolizine Derivatives as Microtubule Destabilizers.

Design, Synthesis, and Selective Antiproliferative Activity of Indolizine Derivatives as Microtubule Destabilizers.

Journal: Archiv der Pharmazie
Published: July 22, 2025

Genomic Insights into Oral Cancer Highlight Mutant SIGMAR1 as a Critical Target to Overcome Chemoresistance.

Genomic Insights into Oral Cancer Highlight Mutant SIGMAR1 as a Critical Target to Overcome Chemoresistance.

Journal: Biochemical genetics
Published: January 30, 2025

Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca2+ dynamics.

Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca2+ dynamics.

Journal: Molecular biology reports
Published: October 25, 2024

SIGMAR1 Knockdown Enhances Oral Cancer Cell Chemosensitivity to Cisplatin via Decreased PD-L1 Expression.

SIGMAR1 Knockdown Enhances Oral Cancer Cell Chemosensitivity to Cisplatin via Decreased PD-L1 Expression.

Journal: International journal of molecular sciences
Published: June 29, 2024

Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53.

Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53.

Journal: The American journal of pathology
Published: June 05, 2024

SET protein as an epigenetics target.

SET protein as an epigenetics target.

Journal: Epigenomics
Published: December 22, 2023

The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents.

The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents.

Journal: Gene
Published: October 03, 2023

Accumulation of sphingosine kinase 2 protein induces malignant transformation in oral keratinocytes associated with stemness, autophagy, senescence, and proliferation.

Accumulation of sphingosine kinase 2 protein induces malignant transformation in oral keratinocytes associated with stemness, autophagy, senescence, and proliferation.

Journal: Biochimica et biophysica acta. Molecular cell research
Published: July 04, 2023

FTY720 increases paclitaxel efficacy in cisplatin-resistant oral squamous cell carcinoma.

FTY720 increases paclitaxel efficacy in cisplatin-resistant oral squamous cell carcinoma.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: June 19, 2023
Showing 1-12 of 65

Last Updated: 09/26/2026